News
The economic calendar in the week ahead wiil be fairly light, with the main event being the release of the Federal Reserve's ...
President Trump said the U.S. is poised to inform many trading partners of unilateral tariff rates of up to 70%, putting ...
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the ...
Expensify has made pricing and marketing adjustments to attract more new users. Read why my Buy rating for EXFY stock is left ...
DOCU remains GAAP profitable with solid top-line growth and a strong net cash balance sheet, supporting resilience in ...
JPMorgan's equity strategists led by Mislav Matejka argue that the so-called "pain trade" -- the market move most against current positioning-- is still higher. "Fundamentally, though, will the ...
What level of tariffs will the U.S. impose on imports and when? Stock futures were falling early Monday as markets were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results